Bruised and battered by its failings with the controversial Alzheimer’s drug Aduhelm, Biogen is looking to right the ship with a new helmsman. The company is on the hunt for a new chief executive officer.
United States health spending is projected to rise 5.3 percent in 2018, reflecting rising prices of medical goods and services and higher Medicaid costs.
The Trump administration proposed changes to Medicare drug plans including limits on opioid prescriptions and rules aimed at reducing drug costs for seniors, such as requiring health insurers to pass on discounts to consumers.
U.S. health insurer Anthem Inc. is pulling back from 16 of 19 pricing regions in California where it offered Obamacare options this year, state officials said.
Tim Price was tapped as Secretary of Health and Human Services and Seema Verna will helm the Centers for Medicare and Medicaid Services per Senate approval.
Theranos is shuttering its clinical labs and wellness centers – which will result in about 340 layoffs, about 40 percent of its workforce – the company announced.
Elizabeth Holmes, the embattled CEO of blood testing company Theranos, will not be allowed to own or operate a blood testing laboratory for two years.
U.S. federal health regulators have proposed banning Theranos Inc founder Elizabeth Holmes from the blood-testing business for at least two years after determining that the company failed to fix deficiencies […]
The U.S. government has suspended new enrollment in Cigna Corp’s Medicare Advantage health plans for seniors and standalone Medicare prescription drug plans, citing noncompliance in its appeals and grievances procedures. […]
What are key trends in the transparency compliance landscape?